maccura(SZ:300463) Xin Lang Cai Jing·2025-10-21 11:00Core Viewpoint - The company has received medical device registration certificates for new products, which will enhance its product portfolio and market competitiveness, positively impacting future operations, although actual sales depend on market promotion effectiveness [1] Product Registration - The company has obtained registration for quality control products for blood cell analyzers, a reagent kit for measuring glial fibrillary acidic protein (using direct chemiluminescence), and calibration products for blood cell analyzers [1] Market Impact - The introduction of these new products is expected to enrich the company's offerings and improve its overall market competitiveness [1] - The actual impact on future revenue remains uncertain and is contingent upon the effectiveness of market promotion strategies [1]